patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: CEO letter to shareholders.

Ya... that quarterly with their chronology was rather depressing huh...

2.16

be able to buy more at 1.56 befor long

e

Share
New Message
Please login to post a reply